We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $931M
1-Year Est. Return 47.97%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+47.97%
3 Year Est. Return
+122.73%
5 Year Est. Return
+132.88%
10 Year Est. Return
AUM
$1.27B
AUM Growth
+$36.7M
Cap. Flow
-$162M
Cap. Flow %
-12.76%
Top 10 Hldgs %
81.63%
Holding
25
New
Increased
3
Reduced
21
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 28%
2 Miscellaneous 27.35%
3 Communication Services 14.79%
4 Healthcare 10.09%
5 Consumer Discretionary 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJR icon
1
iShares Core S&P Small-Cap ETF
IJR
$106B
$187M 14.77%
1,413,412
+507,235
+56% +$60.6M
REGN icon
2
Regeneron Pharmaceuticals
REGN
$80.8B
$128M 10.09%
152,783
+15,741
+11% +$13.2M
IBKR icon
3
Interactive Brokers
IBKR
$40.1B
$123M 9.73%
2,380,176
-954,332
-29% -$40.2M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.23T
$119M 9.35%
533,955
-352,997
-40% -$61.8M
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.09T
$117M 9.22%
219,835
-111,419
-34% -$51.4M
AMZN icon
6
Amazon
AMZN
$2.71T
$88.2M 6.96%
342,812
-39,488
-10% -$8.08M
PM icon
7
Philip Morris
PM
$296B
$70.1M 5.53%
496,648
-52,651
-10% -$6.64M
DFS
8
DELISTED
Discover Financial Services
DFS
$61.4M 4.85%
302,397
-24,813
-8% -$4.07M
FCNCA icon
9
First Citizens BancShares
FCNCA
$23.9B
$53.2M 4.2%
21,487
-3,060
-12% -$6.41M
IBB icon
10
iShares Biotechnology ETF
IBB
$10.5B
$41M 3.24%
264,586
-8,369
-3% -$1.18M
MTCH icon
11
Match Group
MTCH
$10B
$40M 3.16%
1,042,614
-264,537
-20% -$9.07M
CTVA icon
12
Corteva
CTVA
$54.8B
$38.5M 3.04%
576,194
-18,226
-3% -$1.08M
PINS icon
13
Pinterest
PINS
$10.3B
$28.9M 2.28%
849,920
-267,065
-24% -$8.39M
GHC icon
14
Graham Holdings Company
GHC
$4.78B
$16.7M 1.32%
16,376
-3,081
-16% -$2.7M
HLF icon
15
Herbalife
HLF
$1.25B
$10.7M 0.84%
1,599,168
-1,054,746
-40% -$7.84M
RAMP icon
16
LiveRamp
RAMP
$2.31B
$8.77M 0.69%
246,272
-7,802
-3% -$218K
SQM icon
17
Sociedad Química y Minera de Chile
SQM
$20.6B
$5.76M 0.45%
135,201
-4,276
-3% -$167K
BBWI icon
18
Bath & Body Works
BBWI
$3.44B
$5.11M 0.4%
112,578
-19,745
-15% -$660K
MDLZ icon
19
Mondelez International
MDLZ
$79.3B
$4.09M 0.32%
58,445
-3,443
-6% -$228K
RSKD icon
20
Riskified
RSKD
$827M
$2.6M 0.21%
469,260
-14,843
-3% -$68.8K
VRTX icon
21
Vertex Pharmaceuticals
VRTX
$130B
-19,856
Closed -$9.23M

Similar funds

Bronte Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Bronte Capital Management held 25 positions worth $1.27B, up 3% from $1.23B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Bronte Capital Management withdrew a net $162M in Q4 2024, closing 1 position and reducing 21 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $9.23M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Miscellaneous and Communication Services.

Against the trend, Bronte Capital Management added an estimated $60.6M to iShares Core S&P Small-Cap ETF.

  • Bronte Capital Management added most to iShares Core S&P Small-Cap ETF in Q4 2024, an estimated $60.6M increase.
  • Bronte Capital Management's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $61.8M.
  • Bronte Capital Management fully exited Vertex Pharmaceuticals in Q4 2024, selling an estimated $9.23M.
  • Bronte Capital Management's ten largest holdings make up 82% of its $1.27B portfolio in Q4 2024.
  • Bronte Capital Management opened 0 new positions and closed 1 in Q4 2024.
  • Bronte Capital Management's portfolio value rose 3% quarter-over-quarter to $1.27B.

Based on Bronte Capital Management's 13F filing for Q4 2024, filed 10 Feb 2025.